Company Limited (“the Company”) No. 11/2017 held on 30 October, 2017 at 13.00 hrs. has passed the agenda: 1. Appointment of Dr. Aphichat Samoon as the Independent Director to replace the position of
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q1 31/01/2022 2022 Reviewed Consolidated Q1 31/01/2022 2021 Company Year 31/10
) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q3 30/11/2022 2023 Reviewed Consolidated Q3 30/11/2022 2023 Reviewed
Year 31/10/2022 2022 Consolidated Year 31/10/2022 2022 Reviewed Company Q3 31/07/2022 2022 Reviewed Consolidated Q3 31/07/2022 2022 Reviewed Company Q2 30/04/2022 2022
) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q3 30/11/2022 2023 Reviewed Consolidated Q3 30/11/2022 2023 Reviewed
Company Q3 30/11/2024 2025 Reviewed Consolidated Q3 30/11/2024 2025 Reviewed Consolidated Q2 31/08/2024 2025 Reviewed Company Q2 31/08/2024 2025 Reviewed Consolidated Q1 31/05/2024